메뉴 건너뛰기




Volumn 43, Issue SUPPL. 1, 2013, Pages

Ethical Oversight: Serving the Best Interests of Patients

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); EDUCATION; ETHICS; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; HUMAN EXPERIMENT; MORALITY; NOTE; PATIENT CARE; RESEARCH SUBJECT; VOCATIONAL EDUCATION;

EID: 84872420652     PISSN: 00930334     EISSN: 1552146X     Source Type: Journal    
DOI: 10.1002/hast.138     Document Type: Note
Times cited : (16)

References (4)
  • 1
    • 77953647113 scopus 로고    scopus 로고
    • Distributed Health Data Networks: A Practical and Preferred Approach to Multi-Institutional Evaluations of Comparative Effectiveness, Safety, and Quality of Care
    • J.S. Brown et al., "Distributed Health Data Networks: A Practical and Preferred Approach to Multi-Institutional Evaluations of Comparative Effectiveness, Safety, and Quality of Care," Medical Care 48, no. 6, suppl. (2010): S45-S51.
    • (2010) Medical Care , vol.48 , Issue.6 SUPPL.
    • Brown, J.S.1
  • 3
    • 84857315813 scopus 로고    scopus 로고
    • Informed Consent and Cluster-Randomized Trials
    • A.D. McRae, "When Is Informed Consent Required in Cluster Randomized Trials in Health Research?" Trials 12 (2011): 202; C. Weijer, "Ethical Issues Posed by Cluster Randomized Trials in Health Research," Trials 12 (2011): 100; F.G. Miller and E.J. Emanuel, "Quality-Improvement Research and Informed Consent," New England Journal of Medicine 358 (2008): 765-67; R.H. Savel, E.B. Goldstein, and M.A. Gropper, "Critical Care Checklists, the Keystone Project, and the Office for Human Research Protections: A Case for Streamlining the Approval Process in Quality-Improvement Research," Critical Care Medicine 37, no. 2 (2009): 725-28; K.M. Mazor, "Cluster Randomized Trials to Study the Comparative Effectiveness of Therapeutics: Stakeholders' Concerns and Recommendations," Pharmacoepidemiology and Drug Safety 18, no. 7 (2009): 554-61.
    • J. Sim and A. Dawson, "Informed Consent and Cluster-Randomized Trials," American Journal of Public Health 102, no. 3 (2012): 480-85; A.D. McRae et al., "When Is Informed Consent Required in Cluster Randomized Trials in Health Research?" Trials 12 (2011): 202; C. Weijer et al., "Ethical Issues Posed by Cluster Randomized Trials in Health Research," Trials 12 (2011): 100; F.G. Miller and E.J. Emanuel, "Quality-Improvement Research and Informed Consent," New England Journal of Medicine 358 (2008): 765-67; R.H. Savel, E.B. Goldstein, and M.A. Gropper, "Critical Care Checklists, the Keystone Project, and the Office for Human Research Protections: A Case for Streamlining the Approval Process in Quality-Improvement Research," Critical Care Medicine 37, no. 2 (2009): 725-28; K.M. Mazor et al., "Cluster Randomized Trials to Study the Comparative Effectiveness of Therapeutics: Stakeholders' Concerns and Recommendations," Pharmacoepidemiology and Drug Safety 18, no. 7 (2009): 554-61.
    • (2012) American Journal of Public Health , vol.102 , Issue.3 , pp. 480-485
    • Sim, J.1    Dawson, A.2
  • 4
    • 84868318842 scopus 로고    scopus 로고
    • Seeing through the Eyes of Patients: The Patient-Centered Outcomes Research Institute Funding Announcements
    • H.M. Krumholz and J.V. Selby, "Seeing through the Eyes of Patients: The Patient-Centered Outcomes Research Institute Funding Announcements," Annals of Internal Medicine 157, no. 6 (2012): 446-47.
    • (2012) Annals of Internal Medicine , vol.157 , Issue.6 , pp. 446-447
    • Krumholz, H.M.1    Selby, J.V.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.